Contribution of glycerophospholipids and sphingomyelin to the circulating NEFA

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 110, Issue , 2016, Pages 55-61

  Maier, Felicitas ^a   Demmelmair, Hans ^a   Fugmann, Marina ^a,b,c   Hellmuth, Christian ^a   Lechner, Andreas ^a,b,c   Koletzko, Berthold ^a   Uhl, Olaf ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

Long chain polyunsaturated fatty acids; Nonesterified fatty acids; Phospholipids; Postprandial metabolism; Sphingolipids; Very long chain fatty acids

Indexed keywords

GLYCEROPHOSPHOLIPID; LONG CHAIN POLYUNSATURATED FATTY ACID; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; SPHINGOMYELIN; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID; FATTY ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FEEDING; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LIPID COMPOSITION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; TRIPLE QUADRUPOLE MASS SPECTROMETRY; ANIMAL; BLOOD; CASE CONTROL STUDY; GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; PREGNANCY; TANDEM MASS SPECTROMETRY;

ADULT; ANIMALS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DIABETES, GESTATIONAL; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE TOLERANCE TEST; GLYCEROPHOSPHOLIPIDS; HUMANS; POSTPRANDIAL PERIOD; PREGNANCY; SPHINGOMYELINS; TANDEM MASS SPECTROMETRY;

EID: 84975706574     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2016.01.004     Document Type: Article

References (35)

1. Boden G., Shulman G.I. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur. J. Clin. Investig. 2002, 32(Suppl. 3):S14-S23.
2. Novgorodtseva T.P., Karaman Y.K., Zhukova N.V., Lobanova E.G., Antonyuk M.V., Kantur T.A. Composition of fatty acids in plasma and erythrocytes and eicosanoids level in patients with metabolic syndrome. Lipids Health Dis. 2011, 10:82.
3. Frayn K.N. Plasma non-esterified fatty acids: why are we not measuring them routinely?. Ann. Clin. Biochem. 2005, 42(Pt 6):413-414.
4. Hellmuth C., Demmelmair H., Schmitt I., Peissner W., Bluher M., Koletzko B. Association between plasma nonesterified fatty acids species and adipose tissue fatty acid composition. PloS One 2013, 8(10):e74927.
5. Miksztowicz V., Schreier L., McCoy M., et al. Role of SN1 lipases on plasma lipids in metabolic syndrome and obesity. Arterioscler. Thromb. Vasc. Biol. 2014, 34(3):669-675.
6. Emamian M., Avan A., Pasdar A., et al. The lipoprotein lipase S447X and cholesteryl ester transfer protein rs5882 polymorphisms and their relationship with lipid profile in human serum of obese individuals. Gene 2015, 558(2):195-199.
7. Yang Y., Kuwano T., Lagor W.R., et al. Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species. Lipids 2014, 49(6):505-515.
8. Glaser C., Demmelmair H., Koletzko B. High-throughput analysis of total plasma fatty acid composition with direct in situ transesterification. PloS One 2010, 5(8):e12045.
9. Hodson L., Skeaff C.M., Fielding B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 2008, 47(5):348-380.
10. Glaser C., Demmelmair H., Koletzko B. High-throughput analysis of fatty acid composition of plasma glycerophospholipids. J. Lipid Res. 2010, 51(1):216-221.
11. Uhl O., Demmelmair H., Klingler M., Koletzko B. Changes of molecular glycerophospholipid species in plasma and red blood cells during docosahexaenoic acid supplementation. Lipids 2013, 48(11):1103-1113.
12. Mittendorfer B., Liem O., Patterson B.W., Miles J.M., Klein S. What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean?. Diabetes 2003, 52(7):1641-1648.
13. Aloulou A., Ali Y.B., Bezzine S., Gargouri Y., Gelb M.H. Phospholipases: an overview. Methods Mol. Biol. 2012, 861:63-85.
14. Shaner R.L., Allegood J.C., Park H., et al. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J. Lipid Res. 2009, 50(8):1692-1707.
15. Fugmann M., Uhl O., Hellmuth C., et al. Differences in the serum nonesterified Fatty Acid profile of young women associated with a recent history of gestational diabetes and overweight/obesity. PloS One 2015, 10(5):e0128001.
16. Rottenkolber M., Ferrari U., Holland L., et al. The Diabetes Risk Phenotype of Young Women With Recent Gestational Diabetes. J. Clin. Endocrinol. Metab. 2015, 100(6):E910-E918.
17. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22(9):1462-1470.
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
19. Hellmuth C., Weber M., Koletzko B., Peissner W. Nonesterified fatty acid determination for functional lipidomics: comprehensive ultrahigh performance liquid chromatography-tandem mass spectrometry quantitation, qualification, and parameter prediction. Anal. Chem. 2012, 84(3):1483-1490.
20. Karpe F., Dickmann J.R., Frayn K.N. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 2011, 60(10):2441-2449.
21. Kahn S.E. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J. Clin. Endocrinol. Metab. 2001, 86(9):4047-4058.
22. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444(7121):840-846.
23. Al-Goblan A.S., Al-Alfi M.A., Khan M.Z. Mechanism linking diabetes mellitus and obesity. Diabetes Metab. Syndr. Obes.: Targets Ther. 2014, 7:587-591.
24. Davidson M.H. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Curr. Opin. Lipidol. 2013, 24(6):467-474.
25. PC Calder, AD Dangour, C. Diekman, et al., Essential fats for future health, in: Proceedings of the 9th Unilever Nutrition Symposium, 26-27 May 2010, European Journal of Clinical Nutrition. 2010, vol. 64, Suppl 4:S1-S13.
26. Grapov D., Adams S.H., Pedersen T.L., Garvey W.T., Newman J.W. Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. PloS One 2012, 7(11):e48852.
27. Malapaka R.R., Khoo S., Zhang J., et al. Identification and mechanism of 10-carbon fatty acid as modulating ligand of peroxisome proliferator-activated receptors. J. Biol. Chem. 2012, 287(1):183-195.
28. Klingler M., Demmelmair H., Koletzko B., Glaser C. Fatty acid status determination by cheek cell sampling combined with methanol-based ultrasound extraction of glycerophospholipids. Lipids 2011, 46(10):981-990.
29. Yli-Jama P., Haugen T.S., Rebnord H.M., Ringstad J., Pedersen J.I. Selective mobilisation of fatty acids from human adipose tissue. Eur. J. Intern. Med. 2001, 12(2):107-115.
30. Chen S., Subbaiah P.V. Phospholipid and fatty acid specificity of endothelial lipase: potential role of the enzyme in the delivery of docosahexaenoic acid (DHA) to tissues. Biochim. Biophysica Acta 2007, 1771(10):1319-1328.
31. Pruzanski W., Lambeau L., Lazdunsky M., Cho W., Kopilov J., Kuksis A. Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2. Biochim. Biophys. Acta 2005, 1736(1):38-50.
32. Martinez M., Mougan I. Fatty acid composition of human brain phospholipids during normal development. J. Neurochem. 1998, 71(6):2528-2533.
33. Teusink B., Voshol P.J., Dahlmans V.E., et al. Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes 2003, 52(3):614-620.
34. Wolfe R., Durkot M. Role of very low density lipoproteins in the energy metabolism of the rat. J. Lipid Res. 1985, 26(2):210-217.
35. Miles J.M., Nelson R.H. Contribution of triglyceride-rich lipoproteins to plasma free fatty acids. Horm. Metab. Res. 2007, 39(10):726-729.